A clinical trial into treatment for gestational diabetes, involving more than 500 pregnant women, has revealed what the lead academic has described as a significant step forward for women. The research has found benefits for both mothers and their newborn babies, and alleviated concerns over the use of the drug metformin, including less weight gain for mothers; no evidence of increase in preterm birth; and no differences in adverse neonatal outcomes.
Read more …Pregnant women offered new hope for safe and effective gestational diabetes treatment
An individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years, an international team of researchers has warned. Even people who do not develop the condition until later in life – with a diagnosis at age 50 years – could see their life expectancy fall by up to six years, an analysis of data from 19 high-income countries found.
Read more …Type 2 diabetes diagnosis at age 30 can reduce life expectancy by up to 14 years